Scopus by Title (Ref)

SYNTHESIS, CHARACTERIZATION OF CU(II), AG(I), CD(II) AND PD(II) COMPLEXES WITH SCHIFF BASE LIGAND OF NNNO DONOR ATOMS QUADRIDENTATE AND STUDY OF THEIR ANTIOXIDANT AND ANTICANCER ACTIVITIES

Bulletin of Pharmaceutical Sciences Assiut

February 2026

Ashour A.S.J.

Open Access

Novel bis-Thiazolidinone -based chalcones with pyridine linker: Eco-friendly synthesis, cholinesterase and beta-amyloid inhibition potency, and molecular docking studies

Bioorganic Chemistry

January 2026

Gomha S.M.

Small-Molecule Tyrosinase Inhibitors for Treatment of Hyperpigmentation

Molecules

February 2025

Ni X.

Open Access

A new strategy for the treatment of Parkinson's disease: Discovery and bio-evaluation of the first central-targeting tyrosinase inhibitor

Bioorganic Chemistry

September 2024

Qi S.

Design of potent tyrosinase inhibiting N-arylated-4-yl-benzamides bearing 2-aminothiazole-triazole bi-heterocycles: mechanistic insight through enzyme inhibition, kinetics and computational studies

Rsc Advances

21 May 2024

Khan F.M.

Open Access

Recent advances in triazoles as tyrosinase inhibitors

European Journal of Medicinal Chemistry

5 November 2023

Mermer A.

All Open Access, Green

Synthesis, characterization, carbonic anhydrase inhibitor activity, and docking studies of phenylthiazol-2(3h)-ylidene-isoquinoline-5-amine Derivatives

Journal of Molecular Structure

5 November 2023

Berber N.

Open Access

Evaluation of 2,3-Dihydro-1,5-benzothiazepine Derivatives as Potential Tyrosinase Inhibitors: In Vitro and In Silico Studies

ACS Omega

16 May 2023

Al-Rooqi M.M.

Open Access

Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances

International Journal of Molecular Sciences

May 2023

Vittorio S.

Open Access

Tyrosinase Inhibitors Naturally Present in Plants and Synthetic Modifications of These Natural Products as Anti-Melanogenic Agents: A Review

Molecules

January 2023

Hassan M.

Open Access